Retirement

BAFNA PHARMACEUTICALS LIMITED REGD. OFFICE: “BAFNA TOWERS”, NO.299, THAMBU CHETTY STREET, CHENNAI – 600001, TAMIL NADU, INDIA PHONE: 044-25267517/25270992/42677555, FAX: 91-44-25231264, Email: info@bafnapharma.com, Website: www.bafnapharma.com CIN: L24294TN1995PLCO30698 Date: June 22, 2026 BSE Limited, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Mumbai - 400001. Bandra East, Mumbai – 400051. Scrip Code: 532989 Scrip Code: BAFNAPH Dear Sir/Madam, Subject: Disclosure Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Retirement of Independent Director of the Company Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you that Mr. Navin Kumar (DIN: 08778662) will be retiring as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026. Consequently, he will also cease to be the Chairman of the Audit Committee and the Nomination & Remuneration Committee of the Company. Further, we wish to inform you that due to the aforesaid change in composition of the Board of Directors, the following Committees of the Board of Directors have been re-constituted with effect from June 23, 2026, as detailed below: Name of the Name of the Director Designation & Category Committee Mr. Palamadai Krishnan Chairman (Non-Executive, Independent) Sundaresan Mrs. Ravichandran Chitra Member (Non-Executive, Independent) Audit Committee Mr. Upendar Mekala Reddy Member (Non-Executive, Non- Independent) Mr. Palamadai Krishnan Chairman (Non-Executive, Independent) Sundaresan Nomination and Mrs. Ravichandran Chitra Member (Non-Executive, Independent) Remuneration Committee Mrs. Akila Chintalapati Raju Member (Non-Executive, Non- Independent) Factory: No.147, Madhavaram Redhills High Road, Grantlyon Village, Vadakarai Post, Chennai-600 052, TN, India Phone: 9445149001 Email: factory1@bafnapharma.com BAFNA PHARMACEUTICALS LIMITED REGD. OFFICE: “BAFNA TOWERS”, NO.299, THAMBU CHETTY STREET, CHENNAI – 600001, TAMIL NADU, INDIA PHONE: 044-25267517/25270992/42677555, FAX: 91-44-25231264, Email: info@bafnapharma.com, Website: www.bafnapharma.com CIN: L24294TN1995PLCO30698 Notwithstanding the aforesaid retirement of the Independent Director, the composition of the Board and its Committees continues to remain in compliance with the requirements of the applicable laws. The disclosures as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure. We request you take the above information on record. Thanking You. For BAFNA PHARMACEUTICALS LIMITED Mohanachandran A Company Secretary & Compliance Officer Enclosed: As Above Factory: No.147, Madhavaram Redhills High Road, Grantlyon Village, Vadakarai Post, Chennai-600 052, TN, India Phone: 9445149001 Email: factory1@bafnapharma.com BAFNA PHARMACEUTICALS LIMITED REGD. OFFICE: “BAFNA TOWERS”, NO.299, THAMBU CHETTY STREET, CHENNAI – 600001, TAMIL NADU, INDIA PHONE: 044-25267517/25270992/42677555, FAX: 91-44-25231264, Email: info@bafnapharma.com, Website: www.bafnapharma.com CIN: L24294TN1995PLCO30698 Annexure Disclosures as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 as under: Sl. No. Particulars Description 1 Name of Director Mr. Navin Kumar 2 DIN 08778662 3 Reason for change Retirement of Mr. Navin Kumar, as an Independent Director of the Company, upon completion of first term, with effect from June 22, 2026. 4 Date of Cessation Close of Business Hours on June 22, 2026. 5 Brief Profile (in case of Not Applicable appointment) 6 Disclosure of relationships Nil between directors (in case of appointment) Factory: No.147, Madhavaram Redhills High Road, Grantlyon Village, Vadakarai Post, Chennai-600 052, TN, India Phone: 9445149001 Email: factory1@bafnapharma.com